Ledger.Open graph →
SEC Form D · filed November 19, 2021

InflammX Therapeutics, Inc

Offering
$8.4M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Tampa, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David Pool · Tampa, FLExecBrian Levy · Tampa, FLExec · DirectorJames Blair · Tampa, FLDirectorJason Werner · Tampa, FLDirectorPhil Rosenfeld · Tampa, FLDirectorRajiv Shukla · Tampa, FLDirectorDavid Boyer · Tampa, FLDirectorRicky Sim · Tokyo, M0Exec · DirectorKouichi Nanba · Tokyo, M0DirectorMichael Ivey · MCLEAN, VADirectorKoichi Tsukui · Tokyo, M0DirectorKeith Hardwick · Tokyo, M0ExecSayaka Sumida · Tokyo, M0DirectorIsao Sasaki · Tokyo, M0DirectorPost Chad · Birmingham, ALExec · DirectorSamuel G. Sawhook · Corpus Christi, TXExecThibault Manekin · BALTIMORE, MDDirectorMike Vergato · Goffstown, NHDirectorAlan Jerusalmi · Goffstown, NHDirectorThomas Colarusso · Goffstown, NHDirectorBrad Mcgill · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗